Clinical Trial Update: A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers. [Phase 1]

View source ↗

Summary

Phase 1 study comparing a varenicline transdermal patch to oral varenicline in adults who smoke to assess absorption, elimination, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Varenicline (oral) (varenicline)
• Varenicline Transdermal Patch (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 1 | Status: COMPLETED